Browse through 805 product recalls and safety alerts. Filter by hazard level, status, or search for specific products.
Philips Medical Systems Nederland B.V. recalled 45 Allura Xper FD20/10 imaging systems on September 3, 2025. The systems may fail due to internal component deterioration, posing a high risk to users. Affected units include 11 in the U.S. and 34 internationally.
Philips Medical Systems Nederland B.V. recalled 174 OR tables on September 3, 2025. The recall affects models 722023, 722035, and 722015 due to potential failure of motorized movements. Users must stop using these devices immediately to prevent operational issues.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride tablets on September 3, 2025. The recall affects tablets manufactured in India with high levels of a hazardous chemical. Consumers must stop using the product immediately and contact their healthcare provider.
Philips Medical Systems Nederland B.V. recalled the Allura Xper FD20/15 OR Table on September 3, 2025. The recall affects one unit distributed worldwide, including the U.S. Systems may not perform as intended due to internal component deterioration.
Philips Medical Systems recalled 286 Allura Xper FD10/10 imaging systems on September 3, 2025. The recall affects models 722011, 722027, and 722005 due to potential failure of internal components. This malfunction could inhibit motorized movements, posing risks to patient safety.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 100-count bottles of 50 mg tablets due to excessive levels of N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and contact health providers for guidance.
Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects products with NDC 16714-050-01 due to high levels of a chemical impurity. Consumers should stop using the tablets immediately and contact healthcare providers.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 25 mg tablets due to high levels of N-Nitroso Desmethyl Chlorpromazine. Consumers must stop using the product immediately.
Philips Medical Systems Nederland B.V. recalled two operating room tables on September 3, 2025. The recall affects models 722022 and 722033 due to potential system failures. The malfunction can inhibit motorized movements, posing a risk to patients and healthcare providers.
Philips Medical Systems Nederland B.V. recalled 46 imaging systems on September 3, 2025. Deterioration of internal components may lead to loss of motorized movements. Healthcare providers must stop using the systems immediately and follow recall instructions.
Philips Medical Systems Nederland B.V. recalled five Biplane OR Tables on September 3, 2025, due to potential failure of internal components. The recall affects models 722020 and 722025, distributed worldwide. Users must stop using the affected devices immediately to avoid operational issues.
Zydus Lifesciences recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The tablets contain N-Nitroso Desmethyl Chlorpromazine above safe intake levels. Consumers must stop using the product immediately and consult healthcare providers.
Philips Medical Systems Netherlands B.V. recalled 1,117 X-ray imaging systems on September 3, 2025. The recall affects product codes 722010, 722026, and 722003 due to potential internal component deterioration. This issue may render motorized movements inoperable, posing a risk to patient care.
Zydus Lifesciences recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects tablets with NDC 16714-051-01 due to N-Nitroso Desmethyl Chlorpromazine exceeding acceptable limits. Consumers should stop using the product immediately and consult healthcare providers.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The tablets exceed the acceptable limit for N-Nitroso Desmethyl Chlorpromazine. This recall affects the nationwide distribution in the USA.
Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects tablets containing N-Nitroso Desmethyl Chlorpromazine above safe limits. Consumers should stop using the product immediately and consult healthcare providers.
Zydus Pharmaceuticals recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects a specific lot due to contamination with N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 10 mg tablets sold nationwide due to contamination with N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and consult healthcare providers.
Philips Medical Systems recalled 585 Allura Xper FD10/10 imaging systems on September 3, 2025. The BIOS battery may deplete faster than expected, halting system start-up. This affects models 722005, 722011, and 722027 distributed worldwide.
New Spirit Naturals recalled 178 units of Super Muscle Support Powder on September 3, 2025. The product contains an undeclared allergen, milk, posing a serious health risk. Consumers should stop using the product immediately and contact the company for a refund.